Research Site — Teresina, Piauí (PI)

Public research footprint of Research Site, compiled from the ClinicalTrials.gov public registry.

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Non-small Cell Lung Cancer · Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer · Heart Failure and Impaired Kidney Function · Chemotherapy-induced Thrombocytopenia

Recently updated registry entries

NCT07742735 — A Study to Investigate the Efficacy and Safety of Apraglutide Compared With Placebo in… (Recruiting)
NCT06868277 — A Global Phase III Study of Rilvegostomig or Pembrolizumab Monotherapy for First-Line… (Recruiting)
NCT06393374 — Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Research Site?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 03, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.